— Know what they know.
Not Investment Advice

XBI

State Street SPDR S&P Biotech ETF
1W: -0.4% 1M: -6.6% 3M: -3.9% YTD: +27.1% 1Y: +52.4% 3Y: +109.2% 5Y: +18.7%
$154.43
-0.08 (-0.05%)
 
Weekly Expected Move ±3.6%
$143 $149 $154 $160 $165
ETF AMEX · AUM $8.1B

Portfolio Health Summary

IS Overall Score
46.8
★★★★★
Altman Z-Score
19.26
Safe
Weight Coverage
98%
of portfolio analyzed
Holdings Matched
151
with fundamental data

InsiderStreet Scorecard

★★★★★ 46.8
Profitability
40.1
Balance Sheet
57.9
Earnings Quality
51.2
Growth
55.2
Value
36.8
Momentum
61.0
Safety
75.4

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
19.26
Safe Zone (>2.99)
Piotroski F-Score
4.0 / 9
Weak
Beneish M-Score
-4.88
Unlikely Manipulator
Credit Score
—
Earnings Quality
51.2 / 100

Portfolio Valuation

P/E
54.94x
P/B
10.38x
P/S
8.01x
EV/EBITDA
29.21x
EV/Revenue
8.64x
P/FCF
28.11x
P/OCF
25.99x
PEG
3.30x
Earnings Yield
1.82%
FCF Yield
3.56%
OCF Yield
3.85%
Median P/E
-5.77x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +32.8%
Net Income -4.7%
EPS +5.8%
FCF +2.1%
EBITDA +0.4%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +75.2%
Rev CAGR 5Y +38.1%
EPS CAGR 3Y +16.7%
EPS CAGR 5Y +11.1%
FCF CAGR 3Y +35.9%
FCF CAGR 5Y +19.2%
EBITDA CAGR 3Y +12.3%
EBITDA CAGR 5Y +18.2%
Payout Ratio
13.99%
Buyback Yield
0.64%
Dividend Yield
0.12%
Total Shareholder Return
-6.10%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$154.47
Median 1Y
$159.53
5th Pctile
$91.65
95th Pctile
$278.04
Ann. Volatility
33.3%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 54.94
Portfolio P/B 10.38
Portfolio P/S 8.01
EV/EBITDA 29.21
EV/Revenue 8.64
P/FCF 28.11
P/OCF 25.99
PEG 3.30
Earnings Yield 1.82%
FCF Yield 3.56%
OCF Yield 3.85%
Median P/E -5.77
Profitability & Returns (9)
MetricValue
Gross Margin 76.71%
Operating Margin 12.59%
Net Margin 3.53%
FCF Margin 21.30%
ROE 4.70%
ROA 1.55%
ROIC 8.85%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 1.18
Debt/Assets 0.39
Net Debt/EBITDA 1.46
Interest Coverage 2.86
Current Ratio 1.81
Quick Ratio 1.58
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 32.83%
Net Income Growth -4.74%
EPS Growth 5.81%
FCF Growth 2.09%
EBITDA Growth 0.45%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 75.17%
Revenue CAGR 5Y 38.13%
Revenue CAGR 10Y —
EPS CAGR 3Y 16.67%
EPS CAGR 5Y 11.10%
EPS CAGR 10Y —
FCF CAGR 3Y 35.89%
FCF CAGR 5Y 19.23%
FCF CAGR 10Y —
EBITDA CAGR 3Y 12.33%
EBITDA CAGR 5Y 18.25%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 14.47%
Net Income CAGR 5Y 9.85%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 46.8
IS Profitability 40.1
IS Balance Sheet 57.9
IS Earnings Quality 51.2
IS Growth 55.2
IS Value 36.8
IS Momentum 61.0
IS Safety 75.4
IS Quality 53.6
Altman Z-Score 19.26
Piotroski F-Score 3.97
Beneish M-Score -4.88
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 0.12%
Payout Ratio 13.99%
Buyback Yield 0.64%
Total Shareholder Return -6.10%
Growth Stability (4)
MetricValue
Revenue Stability 0.721
Earnings Stability 0.503
Earnings Persistence 0.688
Margin Stability 0.648
Medians (3)
MetricValue
Median P/E -5.77
Median P/B 3.71
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 98.34%
Holdings Matched 151
Total Holdings 159

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms